Details of the Drug Combinations

General Information of This Drug (ID: DML97KB)

Drug Name

TAS-106 DML97KB

Indication

Disease Entry	ICD 11	Status	REF
Head and neck cancer	2D42	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Carboplatin + TAS-106	DCOHHP3	Carboplatin	Cancer	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00737360) Phase II Study of TAS-106 to Treat Head and Neck Cancer. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT00752011) Phase I Study of TAS-106 in Combo With Carboplatin